Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CEA-C008 | Human | ClinMax™ Human Interleukin 2 (IL-2) Quantitative ELISA Kit | |||
CRS-A003 | Human | Human Interleukin-2(IL-2) ELISA Kit | |||
IL2-C5249 | Cynomolgus | Cynomolgus IL-2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL2-H5269 | Human | Human IL-2 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
IL2-M52H3 | Mouse | Mouse IL-2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL2-H52H8 | Human | Human IL-2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
IL2-H82E4 | Human | Biotinylated Human IL-2 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
IL2-H82F3 | Human | Biotinylated Human IL-2 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
IL2-H4113 | Human | Human IL-2 Protein, Tag Free | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Human IL-2 R beta, Fc Tag (Cat. No. ILB-H5253) captured on CM5 chip via anti-human IgG Fc antibody, can bind IL-2, Tag Free (Cat. No. IL2-H4113) with an affinity constant of 0.6 μM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | HIV Infections; Spondylitis, Ankylosing; Myelodysplastic Syndromes; Idiopathic Pulmonary Fibrosis; Multiple Myeloma; HIV Wasting Syndrome; Erythema Nodosum; Leprosy, Lepromatous; Carcinoma, Hepatocellular | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SHR-1916 | SHR-1916 | Phase 1 Clinical | Solid tumours | Details | |
HBAI-20 | HBAI-20; HBAI-20-CyTuVax | Phase 2 Clinical | Cytuvax | Hepatitis B | Details |
Bifikafusp alfa | L19-IL-2 | Phase 3 Clinical | Philogen | Solid tumours; Head and Neck Neoplasms; Carcinoma, Renal Cell; Atherosclerosis; Carcinoma, Basal Cell; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Melanoma | Details |
Interleukin-2 gene therapy (St Jude Children's Research Hospital) | Phase 1 Clinical | St. Jude Children'S Research Hospital, National Cancer Institute | Neuroblastoma | Details | |
T20K | T-20K | Phase 1 Clinical | Cyxone | Multiple Sclerosis | Details |
S-95007 | S-95007 | Phase 2 Clinical | Servier | Immune System Diseases; Inflammation | Details |
Autologous tumor cell vaccine (NCI) | Phase 2 Clinical | H Lee Moffitt Cancer Center & Research Institute, National Cancer Institute, Chiron Spa | Carcinoma, Renal Cell; Melanoma | Details | |
BNT-153 | BNT-153 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |
ITI-1000 | ITI-1000 | Phase 2 Clinical | Immunomic Therapeutics | Glioblastoma | Details |
LMBP2-specific TCR-T cell therapy (TCRCure Biopharma) | Phase 2 Clinical | Tcrcure Biopharma Ltd | Nasopharyngeal Carcinoma | Details | |
mRNA-6231 | mRNA-6231 | Phase 1 Clinical | Autoimmune Diseases | Details | |
RG-6279 | RG-6279 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | Solid tumours | Details |
XTX-202 | XTX-202 | Phase 2 Clinical | Solid tumours | Details | |
STK-012 | STK-012 | Phase 1 Clinical | Synthekine Inc | Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Microsatellite instability-high cancer; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma | Details |
Darleukin/fibromun | L19-IL-2/ L19-TNF-α | Phase 3 Clinical | Philogen | Melanoma | Details |
PM-1016 | PM1016; TILT-123 | Phase 2 Clinical | Tilt Biotherapeutics Ltd | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Melanoma | Details |
NNC-0361-0041 | NNC0361-0041; NNC-0361-0041 | Phase 1 Clinical | Novo Nordisk A/S | Diabetes Mellitus, Type 1 | Details |
This web search service is supported by Google Inc.